Defective ALG3 causes CDG-1d

Stable Identifier
R-HSA-4720475
Type
Pathway
Species
Homo sapiens
Synonyms
Defective ALG3 causes ALG3-CDG
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
Defective ALG3 causes CDG-1d
Click the image above or here to open this pathway in the Pathway Browser
Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (ALG3) adds the sixth mannose (although the first to be derived from dolichyl-phosphate-mannose, DOLPman) to the lipid-linked oligosaccharide (LLO) intermediate GlcNAc(2) Man(5) (PPDol)1 (Korner et al. 1999). Defects in ALG3 are associated with congenital disorder of glycosylation 1d (ALG3-CDG, CDG1d; MIM:601110), a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterised by under-glycosylated serum glycoproteins. CDG type 1 diseases result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency (Sun et al. 2005).
Literature References
PubMed ID Title Journal Year
10581255 Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase

Körner, C, Lehle, L, von Figura, K, Marquardt, T, Stephani, U, Knauer, R

EMBO J. 1999
15840742 Congenital disorder of glycosylation id presenting with hyperinsulinemic hypoglycemia and islet cell hyperplasia

Cohen, J, Chung, WK, Freeze, HH, Wang, C, Eklund, EA, Sun, L

J Clin Endocrinol Metab 2005
Participants
Events
Participates
as an event of
Disease
Authored
Jassal, B  (2013-10-21)
Reviewed
Belaya, K  (2014-10-31)
Created
Jassal, B  (2013-10-21)
Cite Us!